Type: Press Release
… information about the ICD-10 update is available on the CMS website … the heart For additional information please visit wwwabiomedcom FORWARD-LOOKING STATEMENTS This release contains … development of Abiomeds existing and new products the Companys progress toward commercial growth and future …
Type: Press Release
… DANVERS Mass Jan 26 2016 (GLOBE NEWSWIRE) -- Abiomed Inc (NASDAQABMD) announced that on Thursday February 4 2016 the Company will release financial results for the third quarter of fiscal 2016 The Company will host a conference call to discuss the results …
Type: Press Release
… research and technological advances aimed at improving outcomes for acute myocardial infarction cardiogenic shock … Support and Increased Survival Researchers identified 13 studies in the PubMed and Cochrane databases representing 6810 … abstract are available on the SCAI 2022 Scientific Sessions website “These results add to a plurality of evidence that …
Type: Press Release
… DANVERS Mass Oct 26 2017 (GLOBE NEWSWIRE) -- Abiomed Inc (NASDAQABMD) a … fiscal 2018 revenue of $1328 million an increase of 29% compared to revenue of $1030 million for the same period of … conference call to discuss the results on Thursday October 26 2017 at 800 am EDT Michael R Minogue Chairman President …
Type: Press Release
… of Justice that it has closed its investigation into the companys marketing of the Impella® 25 device without taking … We have always remained steadfast in our integrity and our commitment to putting our patients first" said Michael R … President Chief Executive Officer Abiomed On October 26 2012 Abiomed was informed that the United States …
Type: Press Release
… (TCT) 2012 scientific meeting scheduled from October 22 - 26 at the Miami Beach Convention Center in Miami FL "We are … presentations please contact Aimee Genzler Corporate Communications Manager at agenzler@abiomedcom or 978-646-1553 ABOUT ABIOMED Based in Danvers …
Type: Press Release
… 2021 of $2317 million a year over year increase of 5% compared to Q3 fiscal year 2020 despite the negative impact … $2208 million an increase of 4% compared to revenue of $2126 million during Q3 fiscal year 2020 US Impella product … presentation is available on the investor section of our website On January 27 the company received approval from the …
Type: Press Release
… Tuesday January 12 2021 at 520pm EST A live webcast of the Companys presentation at the conference will be available … also be available on the investor section of the companys website at wwwabiomedcom A replay of the webcast will be …
Type: Press Release
… 2022 Second Quarter 2023 Financial Highlights Revenue of $266 million an increase of 11% in constant currency or 7% on … Japan that are the result of three-year investigator-led studies of all Impella-supported patients treated at 109 … live please tune into the webcast via the Johnson & Johnson website ABOUT ABIOMED Based in Danvers Massachusetts USA …
Type: Press Release
… on the latest data from the PROTECT III and Restore EF studies of Impella supported high-risk PCI patients The meeting … join the virtual meeting by logging on to https//infoabiomedcom/TCT-Investor or visiting the investor section of the company’s website at wwwabiomedcom A replay of the October 20 virtual …